Investigating the effect of zinc supplementation on the frequency and duration of colds in children aged 6 to 10 years

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230902059330N1

Enrollment

Registered

2023-09-14

Start date

2023-03-21

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cold. Other viral pneumonia

Interventions

Intervention 1: Intervention group: zinc sulfate supplement 5 mg. Construction of the country of Iran. Razak Laboratories Co. Patients in the intervention group will receive the syrup for 10 days (the

Eligibility

Sex/Gender

All

Age

6 Years to 10 Years

Inclusion criteria

Inclusion criteria: 6-10 years old no underlying disease such as type 1 diabetes, thyroid disorders, heart disorders, etc. no chronic medication such as corticosteroids

Exclusion criteria

Exclusion criteria: Lack of parental consent to participate in the study Lack of access to the patient to follow up on treatment results

Design outcomes

Primary

Measure	Time frame
Duration of cold. Timepoint: 10 days after the start of the study. Method of measurement: Interview and examination.;Number of colds. Timepoint: 10 days after the start of the study. Method of measurement: Interview and examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Mehdi Zarei

Islamic Azad University

2emehdii@gmail.com+98 21 2660 2642

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026